Hallandale Pharmacy (Pharmcore Inc.), Hallandale, FL
Is Hallandale Pharmacy (Pharmcore Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Hallandale Pharmacy (Pharmcore Inc.) hold a Florida pharmacy license?
No license with this exact name and city was found in the Florida Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file covers pharmacy permits at Florida addresses. The file does list Pharmcore (dba Hallandale Pharmacy), FORT LAUDERDALE and PHARMCORE, INC. (dba HALLANDALE PHARMACY COMPOUNDING), FORT LAUDERDALE, a close but not exact match shown below.
Has Hallandale Pharmacy (Pharmcore Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Mar 11, 2020), 1 warning letter close-out (May 3, 2022), 1 state referral letter (May 3, 2022) and 2 FMD-145 letters (May 3, 2022 and Nov 20, 2025) for Hallandale Pharmacy (Pharmcore Inc.). State board actions: no Florida Board of Pharmacy action under this exact name and city was found in the board’s enforcement list for pharmacy permits (actions dated Sep 19, 1980 to Nov 10, 2026) on Nov 15, 2026. The California State Board of Pharmacy’s posted disciplinary decisions on facility licenses also lists “Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended” dated Jun 23, 2022, case AC 7010 on nonresident license NRP 962. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Pharmcore Inc.; Hallandale Pharmacy
- Location
- Hallandale, FL
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 2
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Nov 20, 2025
- FDA Data Dashboard inspections
- No matching site found
- State board records
- No exact match
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Pharmcore Inc. (dba Hallandale Pharmacy), a 503A facility, with 7 dated actions.
| Document | |||
|---|---|---|---|
| Nov 20, 2025 | FMD-145 letter | FMD-145 Letter Issued 11/20/2025 | Not linked by FDA |
| Jun 13, 2025 | Form 483 | 483 Issued 06/13/2025 | fda.gov |
| May 3, 2022 | State referral letter | State Referral Letter Issued 05/03/2022 | FDA copy (archived) |
| May 3, 2022 | FMD-145 letter | FMD-145 Letter Issued 05/03/2022 | Not linked by FDA |
| May 3, 2022 | Warning letter close-out | Warning Letter Close Out Issued 05/03/2022 | Not linked by FDA |
| Sep 24, 2021 | Amended Form 483 | Amended 483 Issued 09/24/2021 | FDA copy (archived) |
| Mar 11, 2020 | Warning letter | Warning Letter (03/11/2020) | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.
The dashboard does list Pharmcore Inc., Fort Lauderdale, FL (FEI 3014480778): same name and state, different city, so not treated as this site.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 2 Form 483 PDFs for Hallandale Pharmacy (Pharmcore Inc.), but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Jun 13, 2025: FDA document 187956: the FEI number and firm name on its cover do not match this page by the rule.
- Sep 24, 2021: FDA document 154256: the FEI number and firm name on its cover do not match this page by the rule.
State board of pharmacy records
No license with this exact name and city was found in the Florida Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file covers pharmacy permits at Florida addresses. Board file.
What this covers: Every enforcement action the Florida Department of Health lists for Board of Pharmacy pharmacy permits, worded as the department gives it. The list includes administrative complaints filed as well as final actions, and links no documents. An administrative complaint is an allegation the department has filed, not a finding. Actions in the data are dated Sep 19, 1980 to Nov 10, 2026.
Close but not exact board records
These board records share a name with this pharmacy but did not meet this index’s matching rule (same name, same city, same state), so they are not treated as its license. They may belong to a separate business.
- License PH19163, Pharmcore (dba Hallandale Pharmacy), FORT LAUDERDALE, status Clear: same name and state, different city.
- License PH28017, PHARMCORE, INC. (dba HALLANDALE PHARMACY COMPOUNDING), FORT LAUDERDALE, status Clear: same name and state, different city.
Nonresident licenses and board actions in other states
These boards list a nonresident license or a board action whose record names this pharmacy’s own name, city and state.
California State Board of Pharmacy, file dated Nov 6, 2026 (California).
- Jun 23, 2022: “Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.”, license NRP 962, case AC 7010, Hallandale Pharmacy, Hallandale, FL. Board document
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- Florida Board of Pharmacy license file
- California State Board of Pharmacy license file
- Florida Board of Pharmacy disciplinary records
- California State Board of Pharmacy disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.